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CASE REPORT
Electrode displacement after intracerebral 
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Objectives: Deep brain stimulation (DBS) is nowadays considered a safe and effective 
procedure for various movement disorders in which conservative treatments have failed to show 
signiﬁ  cant therapeutic results. One of the most common complications of deﬁ  nitive electrode 
positioning is intraparenchymal hemorrhage.
Materials and methods: Authors report the case of a 55-year-old female patient treated for 
Parkinson’s disease in which intraparenchymal hemorrhage developed after DBS procedure, 
leading to signiﬁ  cant (about 8 mm at the neuroradiological controls) displacement of an other-
wise correctly positioned DBS electrode.
Results: After conservative management, the hematoma spontaneously resolved. Late neuro-
radiological controls documented correct, symmetrically positioned electrodes, comparable to 
the immediate postoperative controls.
Conclusions: Six months follow-up endpoint results of the DBS treatment were considered 
satisfying by an independent neurologist, with modest residual neurological deﬁ  cits, demonstrat-
ing that re-positioning of the electrode was unnecessary in this rare complication.
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Introduction
Deep brain stimulation (DBS) procedure is considered a safe and effective therapeutic 
opportunity for patients affected with Parkinson’s disease (PD), such that a well experi-
mented algorithm has been developed to determine surgical indication (the CAPSIT 
examination). Nevertheless, DBS must be considered a surgical procedure, with pos-
sible surgically-related complications which might lead to a post-operative disability 
and mortality.1 The most important adverse event related to the DBS procedure is 
undoubtedly intracranial hemorrhage. Authors present the case of a female patient who 
was treated for PD with DBS and developed post-surgical intraparenchymal hematoma 
with a displacement of the omolateral deﬁ  nitive electrode (neuroradiologically well 
documented with computed tomography [CT] and X-rays). There is a lack of guidelines 
concerning neurosurgical management of such a rare complication, and the indication 
to perform re-positioning of the electrode is thus questionable.
Case report
A 55-year-old woman (AMC) was diagnosed with idiopathic PD at the age of 49 at the 
Parkinson’s disease neurological ward of our Neurosurgical Division by a dedicated 
neurologist (CP). Since the age of 52, unwanted dopamine agonists effects occurred, and 
the disease progressively worsened with motor complications. In January 2006, after 
proper evaluation (CAPSIT protocol), AMC underwent functional neurosurgery for the 


















Figure 2 Computed tomography scan taken after the patient’s health deteoriated, 
documenting frontal intraparenchymal hematoma along the trajectory of the deﬁ  nitive 
electrode.
At the pre STN-DBS evaluation, the Uniﬁ  ed Parkinson’s 
Disease Rating Scale2 part III score in ON was 18 and 34 in 
OFF phase. Involuntary movements were present, with a score 
of 1 at the Goetz scale.3 Mean daily time spent in OFF phase 
lasted three hours. The Mini Mental State Examination4 score 
was 30 (range 0–30). Clinical features were characterized by 
asymmetric plastic hypertonia and hypokinesia and a severe 
trunk dystonia that worsened during standing and during OFF 
phase. The antiparkinsonian therapy consisted of levodopa/
carbidopa 250/25 mg four times a day, entacapone 200 mg 
four times a day, and 4 mg of cabergoline twice a day.
Pre-operative study included 3 mm-sliced, gadolinium-
enhanced T1 axial and sagittal magnetic resonance imaging 
(MRI) and T2 coronal MRI scans of the brain, and a 3 mm-sliced 
CT scan performed with the stereotactic frame. The imaging 
was fused with a neuronavigation device (Stealthstation; 
Medtronic Sofamor Danek, Memphis, TN, USA) together 
with the Schaltenbrand–Wahren Atlas in a well-experimented 
system,5 in order to obtain the stereotactic trajectory with the 
standard subthalamus coordinates of 12 mm lateral to, 4 mm 
posterior at the midcommissural point, and 4 mm under the 
intercommissual plane.
DBS procedure was performed under local anesthesia, 
with the aid of multi (5)-track microrecording and subsequent 
macrostimulation. The left side was operated last: in order to 
minimize cerebrospinal ﬂ  uid leakage, bony chips obtained 
from the burr hole, together with ﬁ  brin glue and oxidized 
cellulose were packed together in order to seal the burr hole 
during electrode advancement towards the target. The central 
track was chosen for each side, and the deﬁ  nitive electrode 
positioning was followed and conﬁ  rmed under ﬂ  uoroscopy. 
The time required for surgery was ﬁ  ve hours and the blood 
loss was negligible.
Immediate postoperative neurological status of the 
patient was followed at the neurosurgical ward and was 
negative. Four hours after surgery the patient underwent a 
control CT scan of the brain (Figure 1), documenting cor-
rect positioning of the stimulating electrodes. A minimal 
(less than 0.5 cm) cortical hematoma on the left side with 
no mass effect was documented. One hour later, right 
hemiparesis and diminished level of consciousness were 
noticed, together with a severe dysarthria, and a further 
control CT scan was obtained: a 3 cm maximum diameter 
cortical–subcortical hematoma was documented, approxi-
mately 25 cc in volume, located in the frontal lobe along the 
electrode’s trajectory, with a signiﬁ  cant local mass-effect 
(Figure 2). After careful discussion considering the absence 
of midline shift, and the absence of a further worsening of Neuropsychiatric Disease and Treatment 2009:6 185
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the clinical picture, conservative management was decided 
upon, and was mainly based on the stability of the clinical 
picture of the patient. The neurological status of the patient 
slowly improved over the following days, and no intensive 
care admission was required. At a CT scan performed eight 
days after STN-DBS, initial lateral displacement of the 
left electrode was noticed, and reached 8 mm lateral to the 
target as measured on the axial plane at a CT scan control 
performed during the 13th postoperative day (Figure 3). The 
patient was dismissed from the neurosurgical ward and sent 
to the Neurology Department in Istituto Mondino one month 
later, after a second surgical procedure for positioning of 
the Kinetra pulse generator (Medtronic Sofamor Danek) in 
a subcutaneous, subclavear pouch.
Kinetra pulse generator was activated 45 days after elec-
trode implantation, after a control CT scan had demonstrated 
a complete readsorption of the hematoma. The images from 
this second CT scan were obtained with an inclination of 
the gantry which was different from the immediate postop-
erative CT control. To address this problem and correctly 
evaluate the position of the left electrode after hematoma 
readsorption, the images were re-calculated with the aid 
of dedicated software (SPM5; Wellcome Trust Centre for 
Neuroimaging, London, UK and Matlab 7.1; Mathworks 
Inc., Natick, MA, USA), applying roto-traslations to the 
CT voxels to obtain slices which were comparable to the 
pre-hematoma pictures (Figure 4). Comparison between the 
two exams documented return of the electrode to a position 
comparable to the immediate postoperative control.
The patient underwent an intensive rehabilitation 
programme, with progressive improvement of the right 
pyramidal syndrome, that six months after the hemorrhage, 
consisted in a slight hypostenia at right limbs, slight dyspha-
gia, and serious dysarthria.
At the evaluation performed six months after surgery, the 
UPDRS part III score was 20 in ON therapy/ON stimulation, 
25 in OFF therapy/ON stimulation, 22 in ON therapy/OFF 
stimulation, and 35 in OFF therapy/OFF stimulation 
OFF phase. Involuntary movements were absent, such as 
OFF phases. The Mini Mental State Examination score was 
30 (range 26–30). Clinical features were characterized by 
slight hypertonia and hypokinesia. The severe trunk dysto-
nia was remitted. The antiparkinsonian therapy consisted in 
levodopa/benserazide 150/37.5 mg four times a day and 1 mg 
of cabergoline twice a day.
Stimulation parameters were set for bilateral bipolar 
stimulation (2+1- and 6+5-) at 3.2 mV of amplitude, 180 Hz 
of pulse frequency and 60 microseconds of pulse width 
after careful regulation, considering side effects and clinical 
improvement. These settings didn’t give rise to side effects.
Discussion
Intraparenchymal hemorrhage is considered the most 










Figure 3 Maximum electrode displacement, as noted on the 13th postoperative day 
control computed tomography scan.
Figure 4 Forty ﬁ  fth postoperative day control computed tomography scan demonstrating 
return of the left deﬁ  nitive electrode to the original position.Neuropsychiatric Disease and Treatment 2009:6 186
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it can occur without clinical worsening.6 According to Binder 
and colleagues7 and to other reports,6,8–10 its incidence is 
believed to be up to 3.3%, with a 0.6% risk of developing new 
neurological deﬁ  cits. There is a lack of data in the literature 
concerning electrode displacement as a consequence of 
such an adverse event. Our results on a large series of DBS 
procedures with this technique are comparable with those of 
well-experienced centers:11 this is the only case of electrode dis-
placement observed in our series of 313 procedures. All these 
patients at our functional neurosurgery facility are screened 
preoperatively for coagulopathy, uncontrolled hypertension, 
or recent use of antiplatelet agents. Neuronavigation is per-
formed on a gadolinium-enhanced MRI scan of the brain 
in order to obtain the safest trajectory for the electrodes. 
Recently, multi-track microrecording exploration has been put 
in correlation with an increased risk of hemorrhage.12 In order 
to minimize mechanical stress, acquisition is performed for 
a minimum of two minutes every 0.5 mm advancement of 
the exploring heads.7 Therefore it is difﬁ  cult to determine 
the exact cause of hematoma formation in this case, which 
is still to be traced back mainly to mechanical stress and 
not to infarction of an ischemic area. Evaluating late imag-
ing results, the displacement of the stimulating electrode is 
probably to be considered a “false image”, due to oedema of 
basal ganglia structures, rather than an effect of mechanical 
distraction exerted by intraparenchymal blood collection, and 
therefore not a real displacement of the electrode from the 
parenchymal structures. Vasogenic edema resolution obtained 
Figure 5 Negative images of the immediate postoperative control and of prolonged follow-up computed tomography (CT) scan are superimposed and scaled (in the square). 
“A” refers to the electrode in the ﬁ  nal position, which is symmetrical to the contralateral, while “B” refers to the electrode as represented in the immediate postoperative 
CT control in which the hematoma had been demonstrated. Note the shift of the electrode compared to the image referred to as “A”. Third ventricle, choroidal plexuses, 
cerebellar vermis, cranial bone, and contralateral electrode are superimposed. Neuropsychiatric Disease and Treatment 2009:6 187
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by careful conservative management of the patient eventually 
led the electrode to its correct positioning, thus avoiding a 
second surgical procedure which was, in fact, unnecessary. 
Moreover, in our opinion, no guidelines could be given solely 
taking into account features of the neuroradiological picture 
such as blood collection volume or electrode displacement 
and without considering the evolution of the clinical picture 
of the patient.13–15
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